subscribe
 

Inflammatory bowel disease

Lipid Therapeutics announces positive topline Phase IIb results with LT-02 in patients with ulcerative colitis



Medical news: Improving inflammatory disease treatments

Researchers completed the first comprehensive analysis of bioactive lipids in an inflammatory response triggered by the Lyme disease agent, Borrelia burgdorferi.



Treatment of inflammatory diseases

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has entered into a collaboration with the Babraham Institute, to further characterize novel treatments for inflammatory diseases through the regulation of phosphatidylinositol-3-kinase - a family of enzymes important to immune cell function.



Inflammatory diseases

Investigators have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis.



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe